Couverture de GLP-1 Muscle Loss — The Hidden Risk - Bimagrumab, Biosensors, and Smarter Weight Loss

GLP-1 Muscle Loss — The Hidden Risk - Bimagrumab, Biosensors, and Smarter Weight Loss

GLP-1 Muscle Loss — The Hidden Risk - Bimagrumab, Biosensors, and Smarter Weight Loss

Écouter gratuitement

Voir les détails

À propos de ce contenu audio

 Ben Synth explores groundbreaking research combining semaglutide with bimagrumab, which produced 22% weight loss—93% from fat while preserving muscle. Plus, emerging wearable sensors could soon monitor muscle breakdown in real-time, revolutionizing how we approach GLP-1 therapy and body composition.

Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

This content was created in partnership and with the help of Artificial Intelligence AI
Aucun commentaire pour le moment